ورود
مقالات فارسیISIکنفرانسهاژورنالها

Effect of Atorvastatin on clinical symptoms and laboratory markers of patients with cholecystitis: A double-blind randomized controlled trial

محل انتشار: مجله جراحی و تروما، دوره: 11، شماره: 1
سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 59

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:
https://civilica.com/doc/1860967

شناسه ملی سند علمی:

JR_JSTR-11-1_001

تاریخ نمایه سازی: 2 دی 1402

چکیده مقاله:

Introduction: Adopting a suitable strategy to reduce the complications of cholecystectomy plays a significant role in the well-being of patients. We investigated the effects of atorvastatin on clinical symptoms, and inflammatory markers of patients undergoing cholecystectomy. Methods: This double-blind randomized controlled trial was conducted in Imam Reza Hospital, Birjand in ۲۰۲۱. In this study, ۴۷ patients received ۴۰ mg atorvastatin (intervention group) and ۴۷ patients received placebo both daily for ۴ weeks (placebo group). Then, the frequency of fever, abdominal pain, and nausea before and after cholecystectomy, as well as peri-operative data (duration of operation, and intraoperative bleeding) and laboratory data [White Blood Count (WBC), C-Reactive Protein (CRP), Aspartate AminoTransferase (AST), and Alkaline Phosphatase (ALT)] was collected. The data was analyzed using (SPSS Version ۲۲) based on chi-squared, and independent t-tests at the significance level of (P≤۰.۰۵). Results: The duration of hospitalization was not significantly different in both groups (P=۰.۲۶), however, the duration of operation was significantly longer in the intervention group (P<۰.۰۰۱). The frequency of fever, abdominal pain, and nausea after cholecystectomy was not statistically different (P>۰.۰۵). The volume of intraoperative bleeding in the placebo group was more than the intervention group (P=۰.۰۵). The decrease of WBC, CRP, and the ALT levels after cholecystectomy was not statistically different (P>۰.۰۵); however, AST level after cholecystectomy was higher in the intervention group (P=۰.۰۵). Conclusions: The use of atorvastatin effectively reduced the volume of intraoperative bleeding. However, this intervention with this dose and duration could not have a significant role in reducing the duration of patients’ hospitalization, duration of operation, and levels of WBC, CRP, ALT, and AST.

کلیدواژه ها:

Cholecystitis ، Acute ، Cholecystectomy ، Atorvastatin ، C-Reactive Protein ، Leukocyte Count ، Aspartate Aminotransferases ، Alanine Transaminase

نویسندگان

Masood Nezamdoost

Student Research Committee, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Mohammad Reza Ghasemian

Cardiovascular Diseases Research Center, Department of Surgery, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Hamid Salehiniya

Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran

Ali Fanoodi

Student Research Committee, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Alireza Rezapanah

Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Mohsen Najmadini

Cardiovascular Diseases Research Center, Department of Surgery, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Shaffer EA. Gallstone disease: Epidemiology of gallbladder stone disease. Best ...
  • Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, ...
  • Bodmer M, Brauchli YB, Krähenbühl S, Jick SS, Meier CR. ...
  • Marschall HU, Einarsson C. Gallstone disease. Journal of internal medicine. ...
  • Schafmayer C, Hartleb J, Tepel J, Albers S, Freitag S, ...
  • Adachi T, Eguchi S, Muto YJJoHBPS. Pathophysiology and pathology of ...
  • Gallaher JR, Charles AJJ. Acute Cholecystitis: A Review. ۲۰۲۲;۳۲۷(۱۰):۹۶۵-۹۷۵ ...
  • Strasberg SM. Cholelithiasis and acute cholecystitis. Baillieres Clin Gastroenterol. ۱۹۹۷;۱۱(۴):۶۴۳-۶۶۱ ...
  • Hanabata Y, Yamanaka K, Shinkura A, Kurimoto M, Aoki H, ...
  • Kiviluoto T, Sirén J, Luukkonen P, Kivilaakso E. Randomised trial ...
  • Trowbridge RL, Rutkowski NK, Shojania KG. Does this patient have ...
  • Strasberg SMJJotACoS. Tokyo guidelines for the diagnosis of acute cholecystitis. ...
  • Lo CM, Liu CL, Fan ST, Lai EC, Wong J. ...
  • Azemawah V, Movahed MR, Centuori P, Penaflor R, Riel PL, ...
  • Patel J, Abd T, Blumenthal RS, Nasir K, Superko HR. ...
  • Squizzato A, Romualdi E, Dentali F, Ageno W. Statins for ...
  • Ruokoniemi P, Helin-Salmivaara A, Klaukka T, Neuvonen PJ, Huupponen R. ...
  • Atorvastatin (Rx): Medscape; [cited ۲۰۲۲. Available from: https://reference.medscape.com/drug/lipitor-atorvastatin-۳۴۲۴۴۶ ...
  • Jakeways MSR, Mitchell V, Hashim IA, Chadwick SJD, Shenkin A, ...
  • Jain MK, Ridker PM. Anti-inflammatory effects of statins: clinical evidence ...
  • Pulkkinen J, Eskelinen M, Kiviniemi V, Kotilainen T, Pöyhönen M, ...
  • Biétry FA, Reich O, Schwenkglenks M, Meier CR. Statin use ...
  • Stinton LM, Myers RP, Shaffer EA. Epidemiology of gallstones. Gastroenterol ...
  • Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Prospective study ...
  • Merzon E, Weiss NS, Lustman AJ, Elhayani A, Dresner J, ...
  • Kim H-S, Lee SH, Kim H, Lee S-H, Cho JH, ...
  • Kamath PS. Clinical Approach to the Patient With Abnormal Liver ...
  • Schirmer BD, Winters KL, Edlich RJJol-teomi. Cholelithiasis and cholecystitis. J ...
    • نمایش کامل مراجع